Skip to content

Effects of perioperative esketamine infusion on acute and chronic pain following video-assisted thoracoscopic lung resection: a multicenter, randomized, double-blind, clinical trial

Effects of perioperative esketamine infusion on acute and chronic pain following video-assisted thoracoscopic lung resection: a multicenter, randomized, double-blind, clinical trial

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040012
Enrollment
Unknown
Registered
2020-11-18
Start date
2021-04-09
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative pain

Interventions

Esketamine group:The esketamine group received an intravenous esketamine bolus (0.1 mg/kg) after induction of anesthesia, followed by a continuous infusion of 0.1 mg/kg/h until the completion of surge
Control group:In the control group, patients received volume-matched saline as both a bolus after induction of anesthesia and a continuous intraoperative infusion. Postoperatively, patient-controlled

Sponsors

The First Affiliated Hospital of Soochow University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. ASA I~III level; 3. Scheduled for elective video-assisted thoracoscopic lung resection under general anesthesia ; 4. Plan to be hospitalized >= 48 hours after surgery.

Exclusion criteria

Exclusion criteria: 1. Known allergy to study medications; 2. Contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs); 3. Psychiatric disorders; 4. History of chronic pain; 5. Communication difficulties; 6. Emergency or trauma cases; 7. History of intraoperative awareness; 8. Planned postoperative transfer to intensive care unit (ICU); 9. Unwilling to use patient controlled intravenous analgesia (PCIA).

Design outcomes

Primary

MeasureTime frame
Incidence of chronic pain;

Secondary

MeasureTime frame
VAS pain score at rest;VAS pain score on coughing;The requirement for supplemental analgesics;Time to recovery of bowel function;hypoxemia;hypotension;nausea and vomiting;itching;dreaminess;nightmare;illusion;delirium;restlessness;orientation difficulty;laryngospasm;blurred vision;tachycardia;salivation;

Countries

China

Contacts

Public ContactJi Fuhai

The First Affiliated Hospital of Soochow University

jifuhai@hotmail.com+86 136 5620 7331

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026